1. Home
  2. SHAK vs DNLI Comparison

SHAK vs DNLI Comparison

Compare SHAK & DNLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shake Shack Inc.

SHAK

Shake Shack Inc.

HOLD

Current Price

$97.14

Market Cap

3.5B

ML Signal

HOLD

Logo Denali Therapeutics Inc.

DNLI

Denali Therapeutics Inc.

HOLD

Current Price

$19.27

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SHAK
DNLI
Founded
2004
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
3.0B
IPO Year
2014
2017

Fundamental Metrics

Financial Performance
Metric
SHAK
DNLI
Price
$97.14
$19.27
Analyst Decision
Buy
Strong Buy
Analyst Count
25
14
Target Price
$116.74
$34.33
AVG Volume (30 Days)
996.4K
1.7M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
354.17
N/A
EPS
1.09
N/A
Revenue
$1,445,306,000.00
N/A
Revenue This Year
$16.58
N/A
Revenue Next Year
$15.07
$408.85
P/E Ratio
$91.31
N/A
Revenue Growth
15.38
N/A
52 Week Low
$76.51
$12.58
52 Week High
$142.23
$23.77

Technical Indicators

Market Signals
Indicator
SHAK
DNLI
Relative Strength Index (RSI) 52.38 45.02
Support Level $85.64 $18.42
Resistance Level $107.47 $20.71
Average True Range (ATR) 3.70 0.95
MACD 0.21 0.01
Stochastic Oscillator 48.47 17.50

Price Performance

Historical Comparison
SHAK
DNLI

About SHAK Shake Shack Inc.

Shake Shack Inc is a roadside burger stand. It serves a classic American menu of premium burgers, hot dogs, crispy chicken, frozen custard, crinkle-cut fries, shakes, beer, wine, and more. The company's burgers are made with a whole-muscle blend of all-natural, hormone and antibiotic-free Angus beef, ground fresh daily, cooked to order, and served on a non-genetically modified organism (GMO) potato bun. Its menu focuses on food and beverages, crafted from a range of classic American foods. The company serves draft Root Beer, seasonal freshly-squeezed lemonade, organic fresh-brewed iced tea, cold brew coffee, organic apple juice, and Shack20 bottled water. Geographically, the company generates the majority of its revenue from the United States.

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. The Company has one operating segment with the goal to discover, develop, and commercializing therapeutics.

Share on Social Networks: